Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results